Burden of illness of bilateral neovascular age-related macular degeneration in Spain

Current Medical Research and Opinion

Volumn 24, Issue 7, 2008, Pages 2103-2111

  Ruiz Moreno, José María ^a   Coco, Rosa María ^b   García Arumí, José ^c   Xu, Xiao ^d   Zlateva, Gergana ^e  

^a UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^b UNIVERSITY OF VALLADOLID   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d Covance Market Access Services Inc   (United States)

^e PFIZER INC   (United States)

Author keywords

Age related macular degeneration; Burden of illness; Choroidal neovascularization; Health resources; Quality of life; Visual acuity

Indexed keywords

ADULT; AGED; CALCULATION; CASE CONTROL STUDY; CLINICAL STUDY; CONFERENCE PAPER; CONFIDENCE INTERVAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DEPRESSION; FEMALE; GENERAL PRACTITIONER; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; QUALITY OF LIFE; RETINA MACULA AGE RELATED DEGENERATION; SPAIN; STATISTICAL SIGNIFICANCE; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COST OF ILLNESS; FEMALE; HEALTH CARE COSTS; HUMANS; INTERVIEWS AS TOPIC; MACULAR DEGENERATION; MALE; MIDDLE AGED; QUALITY OF LIFE; SPAIN; VISUAL ACUITY;

EID: 47949085334     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/03007990802214300     Document Type: Conference Paper

References (25)

1. Ambati J, Ambati BK, Yoo SH, et al. Age-related macular degeneration: etiology, pathogenesis and therapeutic strategies. Surv Ophthalmol 2003;48:257-93
2. Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 1995;39:367-74
3. Maguire MG. Natural history. In: Berger JW, Fine SL, Maguire MG, eds. Age-Related Macular Degeneration. St. Louis, Mo: Mosby;1999:17-30
4. Gottlieb JL. Age-related macular degeneration. JAMA 2002;288:2233-6
5. Seddon JM. Epidemiology of age-related macular degeneration. In: Schachat AP, Ryan SJ, eds. Retina. 3rd edn. St. Louis, Mo: Mosby, 2001:1039-50
6. Ferris III FL, Fine SL, Hyman LA. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol 1984;102:1640-2
7. Augood CA, Vingerling JR, de Jong PT, et al. Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE). Arch Ophthalmol 2006;124:529-35
8. Williams RA, Brody BL, Thomas RG, et al. The psychosocial impact of macular degeneration. Arch Ophthalmol 1998;116:514-20
9. Ivers RQ, Cumming RG, Mitchell P, et al. Visual impairment and falls in older adults: the Blue Mountains Eye Study. J Am Geriatr Soc 1998;46:58-64
10. Brody BL, Gamst AC, Williams RA, et al. Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. Ophthalmology 2001;108:1893-900
11. Soubrane G, Cruess A, Lotery A, et al. Burden and resource utilization of neovascular AMD: findings of a multicountry study. Arch Ophthalmol 2007;125:1249-54
12. Mangione CM, Lee PP, Gutierrez PR, et al. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 2001;119:1050-8
13. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001;33:337-43
14. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997;35:1095-108
15. The EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208
16. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361-70
17. Herrero MJ, Blanch J, Peri JM, et al. A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population. Gen Hosp Psychiatry 2003;25:277-83
18. SOIKOS. Base de datos de costes sanitarios. Version 2.2. Barcelona: SOIKOS;2005
19. Clemons TE, Chew EY, Bressler SB, et al. National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS): AREDS Report No. 10. Arch Ophthalmol 2003;121:211-17
20. Lindblad AS, Clemons TE. Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS Report no. 14. Arch Ophthalmol 2005;123:1207-14
21. Miskala PH, Bressler NM, Meinert CL. Relative contributions of reduced vision and general health to NEI-VFQ scores in patients with neovascular age-related macular degeneration. Arch Ophthalmol 2004;122:758-66
22. Park W. Vision rehabilitation for age-related macular degeneration. Int Ophthalmol Clin 1999;39:143-62
23. Espallargues M, Czoski-Murray CJ, Bansback NJ, et al. The impact of age-related macular degeneration on health status utility values. Invest Ophthalmol Vis Sci. 2005;46:4016-23
24. Bonastre J, Le Pen C, Anderson P, et al. The epidemiology, economics and quality of life burden of age-related macular degeneration in France, Germany, Italy and the United Kingdom. Eur J Health Econ 2002;3:94-102
25. Bonastre J, Le Pen C, Soubrane G, et al. The burden of age-related macular degeneration: results of a cohort study in two French referral centers. Pharmacoeconomics 2003;21:181-90